Integral Health Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47.6M Sell
2,000,000
-575,000
-22% -$11M 1.88% 13
2026
Q1
$45.4M Buy
2,575,000
+375,000
+17% +$7.53M 2.17% 16
2025
Q4
$43.5M Buy
2,200,000
+600,000
+38% +$10.8M 2.16% 9
2025
Q3
$27.9M Buy
1,600,000
+1,200,000
+300% +$17.8M 1.89% 12
2025
Q2
$5.6M Buy
400,000
+200,000
+100% +$3.22M 0.51% 50
2025
Q1
$3.72M Sell
200,000
-300,000
-60% -$4.47M 0.4% 60
2024
Q4
$5.63M Buy
+500,000
New +$5.85M 0.48% 60

Other funds holding ALHC

Integral Health Asset Management's ALHC Position: Q2 2026 in Review

Integral Health Asset Management reduced its Alignment Healthcare (ALHC) stake by 22% in Q2 2026, selling an estimated $11M and leaving 2,000,000 shares worth $47.6M. The position accounts for 1.88% of the portfolio, ranked #13.

Integral Health Asset Management first reported a position in ALHC in Q4 2024 and has held it in 7 quarters since. 323 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Integral Health Asset Management held 2,000,000 shares of Alignment Healthcare worth $47.6M as of Q2 2026.
  • Integral Health Asset Management sold 575,000 Alignment Healthcare shares in Q2 2026, an estimated $11M.
  • Alignment Healthcare made up 1.88% of Integral Health Asset Management's portfolio in Q2 2026, its #13 holding.
  • Integral Health Asset Management first reported a position in Alignment Healthcare in Q4 2024 and has held it in 7 quarters since.
  • 323 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Integral Health Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.